company background image
KIMS logo

Krishna Institute of Medical Sciences NSEI:KIMS Stock Report

Last Price

₹2.06k

Market Cap

₹164.8b

7D

2.8%

1Y

53.0%

Updated

28 Mar, 2024

Data

Company Financials +

Krishna Institute of Medical Sciences Limited

NSEI:KIMS Stock Report

Market Cap: ₹164.8b

KIMS Stock Overview

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India.

KIMS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance2/6
Financial Health4/6
Dividends0/6

Krishna Institute of Medical Sciences Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Krishna Institute of Medical Sciences
Historical stock prices
Current Share Price₹2,059.25
52 Week High₹2,356.40
52 Week Low₹1,346.20
Beta-0.21
1 Month Change-9.00%
3 Month Change4.04%
1 Year Change52.98%
3 Year Changen/a
5 Year Changen/a
Change since IPO106.56%

Recent News & Updates

Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Nov 21
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Aug 23
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Aug 02
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Apr 01
Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Dec 14
Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Aug 13
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Aug 12
Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Jul 02
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

May 08
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

Shareholder Returns

KIMSIN HealthcareIN Market
7D2.8%3.4%2.5%
1Y53.0%62.6%47.3%

Return vs Industry: KIMS underperformed the Indian Healthcare industry which returned 62.6% over the past year.

Return vs Market: KIMS exceeded the Indian Market which returned 47.3% over the past year.

Price Volatility

Is KIMS's price volatile compared to industry and market?
KIMS volatility
KIMS Average Weekly Movement3.2%
Healthcare Industry Average Movement6.2%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: KIMS has not had significant price volatility in the past 3 months.

Volatility Over Time: KIMS's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19734,588Abhinay Bollinenihttps://www.kimshospitals.com

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand name in India. The company offers range of specialties, including cardiac, dental, neuro, oncological, orthopedic, renal, reproductive, and robotic sciences, as well as gastroenterology and hepatology, heart and lung transplant, organ transplantation, mother and childcare, and pediatrics services. It also focuses on accident, biochemistry, anesthesiology, bariatric surgery, andrology and infertility, arthroscopy, alzheimers, bone, joint center specialties, and others.

Krishna Institute of Medical Sciences Limited Fundamentals Summary

How do Krishna Institute of Medical Sciences's earnings and revenue compare to its market cap?
KIMS fundamental statistics
Market cap₹164.80b
Earnings (TTM)₹3.38b
Revenue (TTM)₹24.40b

48.8x

P/E Ratio

6.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KIMS income statement (TTM)
Revenue₹24.40b
Cost of Revenue₹9.76b
Gross Profit₹14.64b
Other Expenses₹11.26b
Earnings₹3.38b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)42.23
Gross Margin60.01%
Net Profit Margin13.85%
Debt/Equity Ratio45.8%

How did KIMS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.